Clinical data and molecular analysis of Mycobacterium tuberculosis isolates from drug-resistant tuberculosis patients in Goiás, Brazil

Drug resistance is one of the major concerns regarding tuberculosis (TB) infection worldwide because it hampers control of the disease. Understanding the underlying mechanisms responsible for drug resistance development is of the highest importance. To investigate clinical data from drug-resistant TB patients at the Tropical Diseases Hospital, Goiás (GO), Brazil and to evaluate the molecular basis of rifampin (R) and isoniazid (H) resistance in Mycobacterium tuberculosis. Drug susceptibility testing was performed on 124 isolates from 100 patients and 24 isolates displayed resistance to R and/or H. Molecular analysis of drug resistance was performed by partial sequencing of the rpoB and katGgenes and analysis of the inhA promoter region. Similarity analysis of isolates was performed by 15 loci mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR) typing. The molecular basis of drug resistance among the 24 isolates from 16 patients was confirmed in 18 isolates. Different susceptibility profiles among the isolates from the same individual were observed in five patients; using MIRU-VNTR, we have shown that those isolates were not genetically identical, with differences in one to three loci within the 15 analysed loci. Drug-resistant TB in GO is caused by M. tuberculosis strains with mutations in previously described sites of known genes and some patients harbour a mixed phenotype infection as a consequence of a single infective event; however, further and broader investigations are needed to support our findings.

Saved in:
Bibliographic Details
Main Authors: Alves,Sueli Lemes de Ávila, Metzker,Fabiana Sarcinelli, Araújo-Filho,João Alves de, Junqueira-Kipnis,Ana Paula, Kipnis,André
Format: Digital revista
Language:English
Published: Instituto Oswaldo Cruz, Ministério da Saúde 2011
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762011000600003
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0074-02762011000600003
record_format ojs
spelling oai:scielo:S0074-027620110006000032015-02-02Clinical data and molecular analysis of Mycobacterium tuberculosis isolates from drug-resistant tuberculosis patients in Goiás, BrazilAlves,Sueli Lemes de ÁvilaMetzker,Fabiana SarcinelliAraújo-Filho,João Alves deJunqueira-Kipnis,Ana PaulaKipnis,André MDR-TB MIRU-VNTR katG rpoB Drug resistance is one of the major concerns regarding tuberculosis (TB) infection worldwide because it hampers control of the disease. Understanding the underlying mechanisms responsible for drug resistance development is of the highest importance. To investigate clinical data from drug-resistant TB patients at the Tropical Diseases Hospital, Goiás (GO), Brazil and to evaluate the molecular basis of rifampin (R) and isoniazid (H) resistance in Mycobacterium tuberculosis. Drug susceptibility testing was performed on 124 isolates from 100 patients and 24 isolates displayed resistance to R and/or H. Molecular analysis of drug resistance was performed by partial sequencing of the rpoB and katGgenes and analysis of the inhA promoter region. Similarity analysis of isolates was performed by 15 loci mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR) typing. The molecular basis of drug resistance among the 24 isolates from 16 patients was confirmed in 18 isolates. Different susceptibility profiles among the isolates from the same individual were observed in five patients; using MIRU-VNTR, we have shown that those isolates were not genetically identical, with differences in one to three loci within the 15 analysed loci. Drug-resistant TB in GO is caused by M. tuberculosis strains with mutations in previously described sites of known genes and some patients harbour a mixed phenotype infection as a consequence of a single infective event; however, further and broader investigations are needed to support our findings.info:eu-repo/semantics/openAccessInstituto Oswaldo Cruz, Ministério da SaúdeMemórias do Instituto Oswaldo Cruz v.106 n.6 20112011-09-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762011000600003en10.1590/S0074-02762011000600003
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Alves,Sueli Lemes de Ávila
Metzker,Fabiana Sarcinelli
Araújo-Filho,João Alves de
Junqueira-Kipnis,Ana Paula
Kipnis,André
spellingShingle Alves,Sueli Lemes de Ávila
Metzker,Fabiana Sarcinelli
Araújo-Filho,João Alves de
Junqueira-Kipnis,Ana Paula
Kipnis,André
Clinical data and molecular analysis of Mycobacterium tuberculosis isolates from drug-resistant tuberculosis patients in Goiás, Brazil
author_facet Alves,Sueli Lemes de Ávila
Metzker,Fabiana Sarcinelli
Araújo-Filho,João Alves de
Junqueira-Kipnis,Ana Paula
Kipnis,André
author_sort Alves,Sueli Lemes de Ávila
title Clinical data and molecular analysis of Mycobacterium tuberculosis isolates from drug-resistant tuberculosis patients in Goiás, Brazil
title_short Clinical data and molecular analysis of Mycobacterium tuberculosis isolates from drug-resistant tuberculosis patients in Goiás, Brazil
title_full Clinical data and molecular analysis of Mycobacterium tuberculosis isolates from drug-resistant tuberculosis patients in Goiás, Brazil
title_fullStr Clinical data and molecular analysis of Mycobacterium tuberculosis isolates from drug-resistant tuberculosis patients in Goiás, Brazil
title_full_unstemmed Clinical data and molecular analysis of Mycobacterium tuberculosis isolates from drug-resistant tuberculosis patients in Goiás, Brazil
title_sort clinical data and molecular analysis of mycobacterium tuberculosis isolates from drug-resistant tuberculosis patients in goiás, brazil
description Drug resistance is one of the major concerns regarding tuberculosis (TB) infection worldwide because it hampers control of the disease. Understanding the underlying mechanisms responsible for drug resistance development is of the highest importance. To investigate clinical data from drug-resistant TB patients at the Tropical Diseases Hospital, Goiás (GO), Brazil and to evaluate the molecular basis of rifampin (R) and isoniazid (H) resistance in Mycobacterium tuberculosis. Drug susceptibility testing was performed on 124 isolates from 100 patients and 24 isolates displayed resistance to R and/or H. Molecular analysis of drug resistance was performed by partial sequencing of the rpoB and katGgenes and analysis of the inhA promoter region. Similarity analysis of isolates was performed by 15 loci mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR) typing. The molecular basis of drug resistance among the 24 isolates from 16 patients was confirmed in 18 isolates. Different susceptibility profiles among the isolates from the same individual were observed in five patients; using MIRU-VNTR, we have shown that those isolates were not genetically identical, with differences in one to three loci within the 15 analysed loci. Drug-resistant TB in GO is caused by M. tuberculosis strains with mutations in previously described sites of known genes and some patients harbour a mixed phenotype infection as a consequence of a single infective event; however, further and broader investigations are needed to support our findings.
publisher Instituto Oswaldo Cruz, Ministério da Saúde
publishDate 2011
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762011000600003
work_keys_str_mv AT alvessuelilemesdeavila clinicaldataandmolecularanalysisofmycobacteriumtuberculosisisolatesfromdrugresistanttuberculosispatientsingoiasbrazil
AT metzkerfabianasarcinelli clinicaldataandmolecularanalysisofmycobacteriumtuberculosisisolatesfromdrugresistanttuberculosispatientsingoiasbrazil
AT araujofilhojoaoalvesde clinicaldataandmolecularanalysisofmycobacteriumtuberculosisisolatesfromdrugresistanttuberculosispatientsingoiasbrazil
AT junqueirakipnisanapaula clinicaldataandmolecularanalysisofmycobacteriumtuberculosisisolatesfromdrugresistanttuberculosispatientsingoiasbrazil
AT kipnisandre clinicaldataandmolecularanalysisofmycobacteriumtuberculosisisolatesfromdrugresistanttuberculosispatientsingoiasbrazil
_version_ 1756383697667358720